Welby Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Welby's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare Services Industry Growth | 19.2% |
| Revenue growth rate | n/a |
| Return on equity | -45.2% |
| Net Margin | -87.8% |
| Next Earnings Update | 14 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Welby makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 575 | -505 | 813 | 0 |
Quality Earnings: 4438 is currently unprofitable.
Growing Profit Margin: 4438 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if 4438's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare 4438's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4438 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (12.5%).
Return on Equity
High ROE: 4438 has a negative Return on Equity (-45.21%), as it is currently unprofitable.